2010
DOI: 10.1016/j.jvs.2010.06.133
|View full text |Cite
|
Sign up to set email alerts
|

CTGF is a Marker of Promigratory Subpopulation of Human Vascular Smooth Muscle Cells: Target for Treatment of Intimal Hyperplasia

Abstract: identity are plastic, and changes are found similar to those previously reported in human vein graft adaptation and animal models. These bioreactors adequately mimic the human arterial environment and enable testing of potential therapeutic agents directed against neointimal hyperplasia. Introduction and objectives:Understanding the processes that control vascular smooth muscle cell (VSMC) phenotypic modulation and determining which subpopulation of VSMCs migrate is critical for the design of treatment of inti… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles